Gene · 116
Papers3,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Assessment of exocrine pancreatic function in children and adolescents with direct and indirect testing. | Front Pediatr | 2022 | 36452348 | PubTator, text mining | PubMed |
| PAC1, VPAC1, and VPAC2 Receptor Expression in Rat and Human Trigeminal Ganglia: Characterization of PACAP-Responsive Receptor Antibodies. | Int J Mol Sci | 2022 | 36430275 | PubTator, text mining | PubMed |
| Intranasal Peptide Therapeutics: A Promising Avenue for Overcoming the Challenges of Traditional CNS Drug Development. | Cells | 2022 | 36429060 | PubTator, text mining | PubMed |
| Trigeminal ganglion itself can be a viable target to manage trigeminal neuralgia. | J Headache Pain | 2022 | 36424545 | PubTator, text mining | PubMed |
| The neuropeptide PACAP alleviates T. gondii infection-induced neuroinflammation and neuronal impairment. | J Neuroinflammation | 2022 | 36403002 | PubTator, text mining | PubMed |
Localization of the neuropeptides pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal peptide, and their receptors in the basal brain blood vessels and trigeminal ganglion of the mouse CNS; an immunohistochemical study. | Front Neuroanat | 2022 | 36387999 | PubTator, text mining | PubMed |
| The main effect and gene-environment interaction effect of the ADCYAP1R1 polymorphism rs2267735 on the course of posttraumatic stress disorder symptoms-A longitudinal analysis. | Front Psychiatry | 2022 | 36386994 | PubTator, text mining | PubMed |
| Understanding VPAC receptor family peptide binding and selectivity. | Nat Commun | 2022 | 36385145 | Swiss-Prot, curated | PubMed |
| Activity-Dependent Neuroprotective Protein (ADNP): An Overview of Its Role in the Eye. | Int J Mol Sci | 2022 | 36362439 | PubTator, text mining | PubMed |
| AmyP53, a Therapeutic Peptide Candidate for the Treatment of Alzheimer's and Parkinson's Disease: Safety, Stability, Pharmacokinetics Parameters and Nose-to Brain Delivery. | Int J Mol Sci | 2022 | 36362170 | PubTator, text mining | PubMed |
| The Role of the Human Microbiome in the Pathogenesis of Pain. | Int J Mol Sci | 2022 | 36362056 | PubTator, text mining | PubMed |
| Migraine Pathophysiology Revisited: Proposal of a New Molecular Theory of Migraine Pathophysiology and Headache Diagnostic Criteria. | Int J Mol Sci | 2022 | 36361791 | PubTator, text mining | PubMed |
| Theragnostic Radionuclide Pairs for Prostate Cancer Management: 64Cu/67Cu, Can Be a Budding Hot Duo. | Biomedicines | 2022 | 36359312 | PubTator, text mining | PubMed |
| Neural Component of the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma. | Cancers (Basel) | 2022 | 36358664 | PubTator, text mining | PubMed |
| Clinical characteristics of combined rosacea and migraine. | Front Med (Lausanne) | 2022 | 36341245 | PubTator, text mining | PubMed |
| Therapeutic applications and potential mechanisms of acupuncture in migraine: A literature review and perspectives. | Front Neurosci | 2022 | 36340786 | PubTator, text mining | PubMed |
| Single-cell RNA-seq transcriptomic landscape of human and mouse islets and pathological alterations of diabetes. | iScience | 2022 | 36339258 | PubTator, text mining | PubMed |
| Discovering a trans-omics biomarker signature that predisposes high risk diabetic patients to diabetic kidney disease. | NPJ Digit Med | 2022 | 36323795 | PubTator, text mining | PubMed |
| The past, present, and future physiology and pharmacology of glucagon. | Cell Metab | 2022 | 36323234 | PubTator, text mining | PubMed |
| Identification of adenylate cyclase 2 methylation in bladder cancer with implications for prognosis and immunosuppressive microenvironment. | Front Oncol | 2022 | 36313639 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/116/papers?page=25